Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.
Brand: WELLBUTRIN
Published 2026-02-05 · Last reviewed 2026-02-12 · 5 references
Content sourced from FDA labeling (DailyMed) and peer-reviewed literature.
Bupropion is an atypical antidepressant (NDRI) used for major depressive disorder, bipolar depression augmentation, and smoking cessation, valued for weight neutrality and low sexual side effects.
Because it is not serotonergic, SSRI-style sexual dysfunction is often less prominent; the trade-off is a more activating profile that can worsen anxiety or insomnia in susceptible patients.
The compare tool can help contrast activation, weight change, and sexual side-effect profiles, and drug-specific evidence summaries can support augmentation and cessation decisions.
The bipolar disorder hub can support mania-prevention planning when bupropion is used in bipolar depression, and the bupropion print view provides patient-friendly counselling sheets.
Activating profile can be useful for fatigue and low motivation, but it is contraindicated in seizure disorders and in current/prior eating disorders; screening for risk factors (alcohol withdrawal, electrolyte disturbances) is important before initiation.
View labelExactRefer to the Glossary entry on Neurotransmitters for background on receptor systems involved in serious mental illness.
Inhibits norepinephrine and dopamine reuptake and antagonizes nicotinic acetylcholine receptors.
Bupropion’s activating profile can be helpful for low energy, but tolerability depends heavily on seizure-risk screening and on a predictable titration plan. Alcohol reduction and minimizing abrupt sedative withdrawal reduce seizure risk; document plans when alcohol use disorder is present. SR/XL tablets should remain intact, and gradual dose changes can reduce insomnia and seizure risk.